|
ZNF713 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.30002691839582E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.48459997020944E-09 |
| Normal-vs-Stage2 |
8.02089999973887E-08 |
| Normal-vs-Stage3 |
1.44120004819115E-09 |
| Normal-vs-Stage4 |
9.92328441640211E-12 |
| Stage1-vs-Stage2 |
4.282600E-01 |
| Stage1-vs-Stage3 |
8.410000E-02 |
| Stage1-vs-Stage4 |
8.827900E-04 |
| Stage2-vs-Stage3 |
4.933600E-01 |
| Stage2-vs-Stage4 |
6.369600E-02 |
| Stage3-vs-Stage4 |
2.504000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.80744308408975E-12 |
| Normal-vs-AfricanAmerican |
1.677710E-03 |
| Normal-vs-Asian |
3.29200000004359E-06 |
| Caucasian-vs-AfricanAmerican |
2.511400E-01 |
| Caucasian-vs-Asian |
3.853400E-01 |
| AfricanAmerican-vs-Asian |
6.445800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.78660000419384E-08 |
| Normal-vs-Female |
1.84530168922947E-12 |
| Male-vs-Female |
9.771600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.86649995038391E-09 |
| Normal-vs-Age(41-60Yrs) |
2.38929986906555E-10 |
| Normal-vs-Age(61-80Yrs) |
1.30479960169794E-10 |
| Normal-vs-Age(81-100Yrs) |
1.601140E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.128800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.395830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.948600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.496400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.093200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.471400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.415120E-04 |
| Classical-VS-Follicular |
7.971800E-01 |
| Classical-VS-Other |
6.105200E-01 |
| Classical-VS-Normal |
2.52370346842667E-11 |
| Tall-VS-Follicular |
8.260300E-03 |
| Tall-VS-Other |
4.133000E-01 |
| Tall-VS-Normal |
6.14286399525099E-12 |
| Follicular-VS-Other |
7.766400E-01 |
| Follicular-VS-Normal |
2.59030000004934E-06 |
| Other-VS-Normal |
8.815600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.33070004909786E-09 |
| Normal-vs-N1 |
2.30879981799603E-10 |
| N0-vs-N1 |
8.617500E-02 |
|
|
